Latest News about LGVN
Recent news which mentions LGVN
   Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  May 09, 2023
  From Benzinga
 
   Why Is Longeveron (LGVN) Stock Up 30% Today?
   
  
  
  May 09, 2023
  From InvestorPlace
 
   Longeveron Doses First Patient In Phase 2 Clinical Trial Of Lomecel-B™ In Japan For Aging-Related Frailty
   
  April 20, 2023
  Tickers 
   LGVN
  
  
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Tuesday
   
  
  
  March 21, 2023
  From Benzinga
 
   Earnings Scheduled For March 10, 2023
   
  
  
  March 10, 2023
  From Benzinga
 From InvestorPlace
 
   3 Penny Stocks That Could Rise 500% in 2023
   
  
  
  January 13, 2023
  From InvestorPlace
 From Benzinga
 From InvestorPlace
 
   Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
   
  
  
  December 13, 2022
  From Benzinga
 
   7 trade ideas for next week
   
  
  
  October 23, 2022
  From AC Investor Blog
 
   How to Find Stocks That Rise 10x
   
  
  
  October 10, 2022
  From InvestorPlace
 
   Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
   
  
  
  October 05, 2022
  From InvestorPlace
 
   12 Health Care Stocks Moving In Thursday's Intraday Session
   
  
  
  September 29, 2022
  From Benzinga
 
   These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
   
  
  
  September 28, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Wednesday's Pre-Market Session
   
  
  
  September 28, 2022
  From Benzinga
 From InvestorPlace
 From Benzinga
 From InvestorPlace
 
   Why Is Longeveron (LGVN) Stock on the Move Today?
   
  
  
  August 31, 2022
  From InvestorPlace
 
   Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
   
  August 31, 2022
  Tickers 
   LGVN
  
  
  From Benzinga
 
   EXCLUSIVE: Longeveron's Lomecel-B Product Gets US FDA Fast Track Designation For Treatment Of Hypoplastic Left Heart Syndrome in Infants
   
  August 31, 2022
  Tickers 
   LGVN
  
  
  From Benzinga
 
   European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy
   
  August 26, 2022
  Tickers 
   LGVN
  
  
  From Benzinga
 
   European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy
   
  August 26, 2022
  Tickers 
   LGVN
  
  
  From Benzinga
 
   12 Health Care Stocks Moving In Wednesday's Pre-Market Session
   
  
  
  August 24, 2022
  From Benzinga
 
   Earnings Scheduled For August 12, 2022
   
  
  
  August 12, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.